Singapore markets closed

Agios Pharmaceuticals, Inc. (AGIO)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
47.52-0.23 (-0.48%)
At close: 4:00PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts1010710
Avg. Estimate-1.59-1.826.01-7.21
Low estimate-2.01-2.2422.21-9.71
High estimate-1.08-1.1127.59-1.48
Year ago EPS-1.43-1.41-4.7426.01
Revenue estimateCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
No. of analysts991010
Avg. Estimate2.6M2.68M4.74M54.97M
Low estimateN/AN/AN/A3.4M
High estimate14.66M14.8M29.46M276.34M
Year ago sales38.02M44.05M203.2M4.74M
Sales growth (year/est)-93.20%-93.90%-97.70%1,059.70%
Earnings history29/09/202030/12/202030/03/202129/06/2021
Est. EPS-1.38-1.33-1.32-1.39
Actual EPS-1.43-1.4126.95-1.41
Difference-0.05-0.0828.27-0.02
Surprise %-3.60%-6.00%2,141.70%-1.40%
EPS trendCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Current estimate-1.59-1.826.01-7.21
7 days ago-1.59-1.826.01-7.21
30 days ago-1.56-1.7326.12-6.78
60 days ago-1.52-1.6526.21-6.43
90 days ago-1.52-1.6525.46-6.41
EPS revisionsCurrent qtr. (Sep 2021)Next qtr. (Dec 2021)Current year (2021)Next year (2022)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A1N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesAGIOIndustrySector(s)S&P 500
Current qtr.-11.20%N/AN/AN/A
Next qtr.-27.70%N/AN/AN/A
Current year648.70%N/AN/AN/A
Next year-127.70%N/AN/AN/A
Next 5 years (per annum)40.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A